InflaRx competitors

InflaRx's competitors include Alexion Pharmaceuticals, La Renon, Tarveda Therapeutics and CorMedix
Add company...
InflaRx
InflaRx develops new therapeutics in the field of acute and chronic inflammation.
Alexion Pharmaceuticals
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.
La Renon
An Indian Pharma House with the motto of Creating a Healthy World converting Science into high end formulations for Chronic illnesses and diseases.
Tarveda Therapeutics
Tarveda Therapeutics takes a novel approach to cancer treatment.
CorMedix
CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.
Founding Date
Founding Date
2006
Founding Date
1992
Founding Date
2007
Founding Date
2011
Founding Date
2006
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Jena, DE HQ
Planegg, DE
Locations
New Haven, US HQ
Buenos Aires, AR
Sydney, AU
Vienna, AT
Brussels, BE
São Paulo, BR
Toronto, CA
see more
Locations
Ahmedabad, IN HQ
Locations
Watertown, US HQ
Locations
Bedminster Township, US HQ
Employees
Employees
9
Employees
2,52519% decrease
Employees
3601% increase
Employees
353% increase
Employees
1456% increase
Valuation ($)
Valuation ($)
848.4 m
Valuation ($)
27.2 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
65.2 m
Facebook likes
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
7.2 k
Facebook likes
N/A
Facebook likes
793
Twitter followers
Twitter followers
N/A
Twitter followers
1.8 k
Twitter followers
138
Twitter followers
N/A
Twitter followers
620

Financial

Revenue (est.)
Revenue (est.)
€108k (FY, 2017)
Revenue (est.)
$3.1b (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$329.3k (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
$258m (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$115k (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
$2.8b (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Gross profit
$214.4k (FY, 2017)
Net income
Net income
(€24.2m) (FY, 2017)
Net income
$399m (FY, 2016)
Net income
N/A
Net income
N/A
Net income
($33m) (FY, 2017)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 16m (over 3 years ago)
Latest funding round
$ 30m (over 1 year ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 16m
Total funding raised
$ 158.6m
Total funding raised
$ 11.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Alexion Pharmaceuticals
HQ
New Haven, US
Employees
2,525↓ 19% decrease

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.

View company
La Renon
HQ
Ahmedabad, IN
Employees
360↑ 1% increase

An Indian Pharma House with the motto of Creating a Healthy World converting Science into high end formulations for Chronic illnesses and diseases.

View company
Tarveda Therapeutics
HQ
Watertown, US
Employees
35↑ 3% increase

Tarveda Therapeutics takes a novel approach to cancer treatment.

View company
CorMedix
HQ
Bedminster Township, US
Employees
14

CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.

View company